Newlands Management Operations’s Moderna MRNA Stock Holding History

Newlands Management Operations’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$307K	Buy	+6,053	New	+$282K	﹤0.01%	16
2025 Q1	–	Sell	-6,053	Closed	-$252K	–	25
2024 Q4	$252K	Hold	6,053	–	–	﹤0.01%	25
2024 Q3	$405K	Hold	6,053	–	–	﹤0.01%	21
2024 Q2	$719K	Hold	6,053	–	–	0.01%	20
2024 Q1	$645K	Hold	6,053	–	–	0.01%	28
2023 Q4	$602K	Hold	6,053	–	–	0.01%	28
2023 Q3	$625K	Hold	6,053	–	–	0.01%	28
2023 Q2	$735K	Hold	6,053	–	–	0.01%	27
2023 Q1	$930K	Hold	6,053	–	–	0.02%	22
2022 Q4	$1.09M	Buy	+6,053	New	+$990K	0.03%	22

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newlands Management Operations's MRNA Position: Q1 2026 in Review

Newlands Management Operations opened a new position in Moderna (MRNA) in Q1 2026: 6,053 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #16 among its holdings. This is a return to the name: Newlands Management Operations previously reported a position in MRNA as recently as Q4 2024.

Newlands Management Operations first reported a position in MRNA in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.09M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Newlands Management Operations held 6,053 shares of Moderna worth $307K as of Q1 2026.
Moderna was a new Newlands Management Operations position in Q1 2026.
Moderna made up ﹤0.01% of Newlands Management Operations's portfolio in Q1 2026, its #16 holding.
Newlands Management Operations first reported a position in Moderna in Q4 2022 and has held it in 10 quarters since.
Newlands Management Operations's Moderna position peaked at $1.09M in Q4 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Newlands Management Operations's 13F filing for Q1 2026, filed 15 May 2026.